undamentalytics Newsletter
Sign in

Viemed Healthcare, Inc. income statement

In fiscal 2025, Viemed Healthcare, Inc. reported revenue of $270m, up 20.5% on the year before, operating income of $22.9m (a 8.5% margin) and net income of $14.9m, or $0.37 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue6480131117139183224270302
Cost of revenue17245144547091115128
Gross profit4856807385113133155173
Research and development011233332
Selling, general and administrative344153556888106121136
Operating income1092712814182323
Income before tax1092613914162221
Income tax00−5334566
Net income109329610111514
Diluted EPS$0.24$0.21$0.78$0.22$0.16$0.25$0.28$0.37$0.36
Diluted shares (average)40m40m41m41m40m40m41m41m41m
EBITDA141536232436435239

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: DCGO vs VMDDLHC vs VMDCDNA vs VMD

More: Health Care Services stocks compared, Health Care sector, rankings of US companies

Figures from Viemed Healthcare, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Viemed Healthcare, Inc.